PC Slower Than It Used to Be?
A free scan shows the junk files, broken settings and background clutter dragging Windows down - then fixes them in one click.Free scan · Windows 10 & 11Crashes, No Sound, or Screen Glitches?
Random freezes, missing sound and display glitches usually trace back to one bad driver. Find and replace yours safely.Free scan · under a minuteProtesters opposing Palantir’s NHS role say the NHS should not entrust a private US technology company with systems involving sensitive health information without stronger public accountability, trust and evidence of benefit. NHS England and Palantir describe a different balance: NHS organisations direct how the Federated Data Platform (FDP) is used, safeguards apply, and the software is intended to help coordinate care and operations. The dispute is not evidence that NHS data has been misused; it is a debate about control, safeguards, public confidence and whether the claimed gains have been robustly demonstrated.
What happened in the nationwide protests?
On 1 October 2026, demonstrations against the FDP took place in 45 locations across more than 30 UK cities, according to TechRadar’s account published the following day. The outlet reported participation by former and current health workers, Amnesty International and Good Law Project campaigners, and other concerned residents. Bristol was among the reported locations, while TechRadar described a much larger action outside Palantir’s London offices. Those are the outlet’s figures and descriptions, not an independently audited organiser tally.
As an Amazon Associate I earn from qualifying purchases.
The action followed a June protest at the NHS ConfedExpo in Manchester. WIRED reported around 80 demonstrators organised by Pull the Plug, with Amnesty International and Unison among those attending. Their objections included privacy, national security and Palantir’s political associations. “Hands off our NHS, hands off our health data” was among the chants reported there; “No Palantir in our NHS” is another campaign slogan.
What is the Federated Data Platform meant to do?
The FDP is an NHS England programme intended to help NHS organisations bring information held in separate databases together so it can support patient care, operational performance and decision-making. The stated aims include better coordination of care and NHS operations. It is an operational platform, not a single national patient database in the ordinary sense of that description: its purpose is to help organisations work with information held across separate systems. The sources reviewed do not establish that every NHS organisation has adopted it.
#1 Best Overall
Palantir supplies the software. TechRadar describes the company’s role under the contract as that of a data processor, while NHS organisations control how information is used. Palantir says it processes data according to NHS instructions and that data remains in the UK. The NHS has described safeguards including encryption, network security and access based on purpose. These are important elements of the stated arrangement, but do not by themselves answer every question about how access is governed in practice, how the public can scrutinise it, or whether people trust the model.
What are campaigners asking the NHS to reject?
Opponents’ concerns span both data governance and the company’s wider role. Campaigners cite patient privacy, security, public trust and accountability, as well as the presence of a US technology company in NHS systems and Palantir’s work for law-enforcement and military customers. Those are arguments for opposing the contract; the reporting reviewed does not establish that Palantir has improperly used NHS data.
Keep Our NHS Public says it supports using health data for research and service planning when public interest, ethics and human rights come first, but opposes the exploitation of personal health data for profit. Amnesty UK’s local-group update says the organisation launched a campaign on 19 March 2026 calling for the contract to be terminated. It describes local campaigning over NHS Trust adoption as a way to put pressure on NHS England. Pull the Plug co-founder Frieda Lurken told WIRED: “We want ordinary people to get a say in how AI is used in our lives.”
There has also been parliamentary concern, but its formal status matters. An Early Day Motion used the phrase “hands off our NHS” and raised concerns about NHS data contracts awarded to Palantir. Parliament’s page lists five signatories and records that the motion was withdrawn. It was not a resolution of the House or a statement of government policy.
How do NHS England and Palantir describe the case for the platform?
NHS data and analytics director Ayub Bhayat told WIRED that the FDP is helping patients while saving money for NHS teams and taxpayers. He also said, “There is no requirement for its use.” The sources describe local NHS organisations as able to decide whether to adopt the platform: Keep Our NHS Public says Trusts and integrated care systems must make that choice, and WIRED reported that Greater Manchester’s NHS division declined the FDP and used in-house analytics instead.
Palantir’s UK head of health partnerships, Stephen Childs, gave WIRED outcome figures. TechRadar reported the company’s claims of 117,000 additional operations, a 14.3 per cent reduction in discharge delays for long-stay patients, and a 5.6 per cent improvement in the number of people finding out whether they have cancer within 28 days. These are company-reported figures, not independently verified estimates of effects caused by the FDP.
What is established—and what remains disputed?
The central evidence question is whether reported improvements can be attributed to the platform rather than to other changes, and whether they are measured consistently. TechRadar reported that the Financial Times said in June 2026 that NHS England acknowledged its main FDP benefit claims were not backed by robust evidence, and that MPs called for an audit. The sources reviewed establish no independent study or audit giving a definitive causal estimate of the platform’s effect. The headline figures therefore describe Palantir’s reported outcomes, not settled proof of impact.
Free tools Windows power users keep installed
One-click scans. No signup required.
That gap does not show that the platform has had no benefit. It does mean readers should distinguish three things: the FDP’s intended functions, outcomes the company says have occurred, and independently established evidence that the software itself produced those outcomes. The reporting cited here supports the first two descriptions, but not a definitive causal conclusion on the third.
Independent reader supportYour contribution helps us test, update, and keep practical guides available for everyone.How do the competing positions compare?
| Question | Campaigners’ concern or position | NHS or Palantir’s stated position | What the reporting establishes |
|---|---|---|---|
| Data access and security | Campaigners raise privacy, security and trust concerns. | TechRadar describes Palantir as a processor acting on NHS instructions; Palantir says data remains in the UK. The NHS describes encryption, network security and purpose-based access. | These safeguards and roles are described in reporting; they do not settle every practical privacy or accountability concern. |
| Local NHS control | Campaigners seek pressure against adoption and the contract. | Bhayat said there is no requirement for Trusts to use the platform. | Local choice is described by Keep Our NHS Public and WIRED; WIRED reported Greater Manchester declined the FDP and used in-house analytics. |
| Transparency and public trust | Campaigners want public say and accountability over health-data use. | The materials cited describe NHS control and stated safeguards, but do not provide a comprehensive account of public-consent arrangements. | The campaign’s call for public involvement is documented; the reporting reviewed does not resolve the broader consent and trust debate. |
| Patient and operational benefits | Opponents challenge whether claimed gains justify the arrangement without robust evidence. | Palantir publicised improvements in operations, discharge delays and cancer waiting-time information. | TechRadar reported that NHS England’s main benefit claims lacked robust evidence; no definitive independent causal estimate was established in the sources reviewed. |
| Cost and alternatives | Keep Our NHS Public opposes exploitation of personal health data for profit. | WIRED reported that Greater Manchester used in-house analytics instead of the FDP. | The reporting cited here does not establish a comparable cost for the FDP and in-house alternative. It also does not establish the current executed contract value or renewal and break-clause terms. |
| Palantir’s other customers | Campaigners cite the company’s law-enforcement and military work as part of their political and ethical objection. | The NHS and Palantir’s reported safeguards and processor arrangement address data handling, not those wider political objections. | The objections are campaigners’ stated position; they are distinct from evidence of misuse of NHS data. |
The £330 million figure sometimes attached to descriptions of the deal should not be treated as a verified current contract value on the basis of the reporting cited here. The current renewal and break-clause status is also unresolved in those accounts; no date or renewal outcome can be stated with confidence.
What should readers watch for next?
The debate turns on decisions and evidence that can be assessed separately. Local NHS organisations’ adoption choices show that the platform is not described as compulsory for every Trust. NHS England’s safeguards and Palantir’s processor role provide a basis for examining who directs access and how the system is secured. And an independent evaluation capable of testing causal impact would help distinguish reported service changes from gains attributable to the FDP itself. None of those points makes the campaigners’ political objections disappear; they clarify which parts of the dispute are about evidence and governance, and which are about whether Palantir should have an NHS role at all.
Laura Gilbert, senior director of AI at the Tony Blair Institute, told WIRED: “It’s exactly the use case that you don’t outsource, and you certainly don’t outsource outside the country.” That is her opinion, not an established technical conclusion. The case for or against the FDP ultimately depends on how readers weigh NHS control and reported safeguards against questions of trust, political accountability and evidence of benefit.
Do these 3 things before closing this tab:
1Repair Windows errors before they cause bigger problems2Fix the driver behind crashes, sound loss and screen glitches3Clear out junk files and repair common Windows errorsQuick Recap
Product prices and availability are accurate as of the date/time indicated and are subject to change. Any price and availability information displayed on Amazon at the time of purchase will apply.
